The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Computational Immunology-Global Market Insights and Sales Trends 2024
Synopsis
Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
The global Computational Immunology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Computational Immunology in various end use industries. The expanding demands from the Allergy Prediction Databases, Analysis Resource Database, International Immunogenetics System and The Ontology of Immune Epitopes, are propelling Computational Immunology market. Cancer Diagnosis & Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reverse Vaccinology segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Computational Immunology market, driven by demand from China, the second largest economy with some signs of stabilising, the Computational Immunology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Computational Immunology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Computational Immunology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Computational Immunology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Computational Immunology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Computational Immunology covered in this report include EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group and Compugen, etc.
The global Computational Immunology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
Global Computational Immunology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Computational Immunology market, Segment by Type:
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
Global Computational Immunology market, by Application
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology of Immune Epitopes
Immune Epitope Database
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Computational Immunology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
The global Computational Immunology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Computational Immunology in various end use industries. The expanding demands from the Allergy Prediction Databases, Analysis Resource Database, International Immunogenetics System and The Ontology of Immune Epitopes, are propelling Computational Immunology market. Cancer Diagnosis & Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reverse Vaccinology segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Computational Immunology market, driven by demand from China, the second largest economy with some signs of stabilising, the Computational Immunology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Computational Immunology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Computational Immunology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Computational Immunology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Computational Immunology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Computational Immunology covered in this report include EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group and Compugen, etc.
The global Computational Immunology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
Global Computational Immunology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Computational Immunology market, Segment by Type:
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
Global Computational Immunology market, by Application
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology of Immune Epitopes
Immune Epitope Database
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Computational Immunology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Computational Immunology
1.1 Computational Immunology Market Overview
1.1.1 Computational Immunology Product Scope
1.1.2 Computational Immunology Market Status and Outlook
1.2 Global Computational Immunology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Computational Immunology Market Size by Region (2018-2029)
1.4 Global Computational Immunology Historic Market Size by Region (2018-2023)
1.5 Global Computational Immunology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Computational Immunology Market Size (2018-2029)
1.6.1 North America Computational Immunology Market Size (2018-2029)
1.6.2 Europe Computational Immunology Market Size (2018-2029)
1.6.3 Asia-Pacific Computational Immunology Market Size (2018-2029)
1.6.4 Latin America Computational Immunology Market Size (2018-2029)
1.6.5 Middle East & Africa Computational Immunology Market Size (2018-2029)
2 Computational Immunology Market by Type
2.1 Introduction
2.1.1 Cancer Diagnosis & Therapy
2.1.2 Reverse Vaccinology
2.1.3 Immune System Modeling
2.2 Global Computational Immunology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Computational Immunology Historic Market Size by Type (2018-2023)
2.2.2 Global Computational Immunology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Computational Immunology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Computational Immunology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Computational Immunology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Computational Immunology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Computational Immunology Revenue Breakdown by Type (2018-2029)
3 Computational Immunology Market Overview by Application
3.1 Introduction
3.1.1 Allergy Prediction Databases
3.1.2 Analysis Resource Database
3.1.3 International Immunogenetics System
3.1.4 The Ontology of Immune Epitopes
3.1.5 Immune Epitope Database
3.2 Global Computational Immunology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Computational Immunology Historic Market Size by Application (2018-2023)
3.2.2 Global Computational Immunology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Computational Immunology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Computational Immunology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Computational Immunology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Computational Immunology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Computational Immunology Revenue Breakdown by Application (2018-2029)
4 Computational Immunology Competition Analysis by Players
4.1 Global Computational Immunology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Computational Immunology as of 2022)
4.3 Date of Key Players Enter into Computational Immunology Market
4.4 Global Top Players Computational Immunology Headquarters and Area Served
4.5 Key Players Computational Immunology Product Solution and Service
4.6 Competitive Status
4.6.1 Computational Immunology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 EpiVax
5.1.1 EpiVax Profile
5.1.2 EpiVax Main Business
5.1.3 EpiVax Computational Immunology Products, Services and Solutions
5.1.4 EpiVax Computational Immunology Revenue (US$ Million) & (2018-2023)
5.1.5 EpiVax Recent Developments
5.2 Novozymes Biopharma
5.2.1 Novozymes Biopharma Profile
5.2.2 Novozymes Biopharma Main Business
5.2.3 Novozymes Biopharma Computational Immunology Products, Services and Solutions
5.2.4 Novozymes Biopharma Computational Immunology Revenue (US$ Million) & (2018-2023)
5.2.5 Novozymes Biopharma Recent Developments
5.3 ioGenetics
5.3.1 ioGenetics Profile
5.3.2 ioGenetics Main Business
5.3.3 ioGenetics Computational Immunology Products, Services and Solutions
5.3.4 ioGenetics Computational Immunology Revenue (US$ Million) & (2018-2023)
5.3.5 International Society of Vaccines Recent Developments
5.4 International Society of Vaccines
5.4.1 International Society of Vaccines Profile
5.4.2 International Society of Vaccines Main Business
5.4.3 International Society of Vaccines Computational Immunology Products, Services and Solutions
5.4.4 International Society of Vaccines Computational Immunology Revenue (US$ Million) & (2018-2023)
5.4.5 International Society of Vaccines Recent Developments
5.5 IMGT
5.5.1 IMGT Profile
5.5.2 IMGT Main Business
5.5.3 IMGT Computational Immunology Products, Services and Solutions
5.5.4 IMGT Computational Immunology Revenue (US$ Million) & (2018-2023)
5.5.5 IMGT Recent Developments
5.6 Dassault Systemes
5.6.1 Dassault Systemes Profile
5.6.2 Dassault Systemes Main Business
5.6.3 Dassault Systemes Computational Immunology Products, Services and Solutions
5.6.4 Dassault Systemes Computational Immunology Revenue (US$ Million) & (2018-2023)
5.6.5 Dassault Systemes Recent Developments
5.7 Certara
5.7.1 Certara Profile
5.7.2 Certara Main Business
5.7.3 Certara Computational Immunology Products, Services and Solutions
5.7.4 Certara Computational Immunology Revenue (US$ Million) & (2018-2023)
5.7.5 Certara Recent Developments
5.8 Chemical Computing Group
5.8.1 Chemical Computing Group Profile
5.8.2 Chemical Computing Group Main Business
5.8.3 Chemical Computing Group Computational Immunology Products, Services and Solutions
5.8.4 Chemical Computing Group Computational Immunology Revenue (US$ Million) & (2018-2023)
5.8.5 Chemical Computing Group Recent Developments
5.9 Compugen
5.9.1 Compugen Profile
5.9.2 Compugen Main Business
5.9.3 Compugen Computational Immunology Products, Services and Solutions
5.9.4 Compugen Computational Immunology Revenue (US$ Million) & (2018-2023)
5.9.5 Compugen Recent Developments
5.10 Genedata AG
5.10.1 Genedata AG Profile
5.10.2 Genedata AG Main Business
5.10.3 Genedata AG Computational Immunology Products, Services and Solutions
5.10.4 Genedata AG Computational Immunology Revenue (US$ Million) & (2018-2023)
5.10.5 Genedata AG Recent Developments
5.11 Insilico Biotechnology AG
5.11.1 Insilico Biotechnology AG Profile
5.11.2 Insilico Biotechnology AG Main Business
5.11.3 Insilico Biotechnology AG Computational Immunology Products, Services and Solutions
5.11.4 Insilico Biotechnology AG Computational Immunology Revenue (US$ Million) & (2018-2023)
5.11.5 Insilico Biotechnology AG Recent Developments
5.12 Leadscope Inc
5.12.1 Leadscope Inc Profile
5.12.2 Leadscope Inc Main Business
5.12.3 Leadscope Inc Computational Immunology Products, Services and Solutions
5.12.4 Leadscope Inc Computational Immunology Revenue (US$ Million) & (2018-2023)
5.12.5 Leadscope Inc Recent Developments
5.13 Nimbus Discovery
5.13.1 Nimbus Discovery Profile
5.13.2 Nimbus Discovery Main Business
5.13.3 Nimbus Discovery Computational Immunology Products, Services and Solutions
5.13.4 Nimbus Discovery Computational Immunology Revenue (US$ Million) & (2018-2023)
5.13.5 Nimbus Discovery Recent Developments
5.14 Strand Life Sciences
5.14.1 Strand Life Sciences Profile
5.14.2 Strand Life Sciences Main Business
5.14.3 Strand Life Sciences Computational Immunology Products, Services and Solutions
5.14.4 Strand Life Sciences Computational Immunology Revenue (US$ Million) & (2018-2023)
5.14.5 Strand Life Sciences Recent Developments
5.15 Schrodinger
5.15.1 Schrodinger Profile
5.15.2 Schrodinger Main Business
5.15.3 Schrodinger Computational Immunology Products, Services and Solutions
5.15.4 Schrodinger Computational Immunology Revenue (US$ Million) & (2018-2023)
5.15.5 Schrodinger Recent Developments
5.16 Simulation Plus
5.16.1 Simulation Plus Profile
5.16.2 Simulation Plus Main Business
5.16.3 Simulation Plus Computational Immunology Products, Services and Solutions
5.16.4 Simulation Plus Computational Immunology Revenue (US$ Million) & (2018-2023)
5.16.5 Simulation Plus Recent Developments
5.17 Rosa & Co
5.17.1 Rosa & Co Profile
5.17.2 Rosa & Co Main Business
5.17.3 Rosa & Co Computational Immunology Products, Services and Solutions
5.17.4 Rosa & Co Computational Immunology Revenue (US$ Million) & (2018-2023)
5.17.5 Rosa & Co Recent Developments
6 North America
6.1 North America Computational Immunology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Computational Immunology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Computational Immunology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Computational Immunology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Computational Immunology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Computational Immunology Market Dynamics
11.1 Computational Immunology Industry Trends
11.2 Computational Immunology Market Drivers
11.3 Computational Immunology Market Challenges
11.4 Computational Immunology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
